Skip to main content

Clinical Trials

Learn about clinical trials for new diabetes treatments, technology, and care programs that may be recruiting people with diabetes in your area.

Finding a clinical trial doesn't have to be complicated. Click "start" to begin. 

 

 

Additional reading: Why Should You Consider Participating in Diabetes Research?

What's new

As scientific researchers continue to make strides toward a cure for type 1 diabetes, diaTribe sat down with Sean Kramer, the CEO of the Diabetes Research Institute Foundation and a person with type 1 himself, to discuss the latest in the search for a cure. Continue Reading »

For relatives of people with type 1 diabetes (T1D), about 5% have certain antibodies associated with causing T1D. By joining this clinical trial, you or your relatives could contribute to the future of prevention and early treatment of T1D. Continue Reading »

Over the past year, diaTribe has continued to work towards our goal to create and publish helpful information to improve the lives of people with diabetes. From vaccine rollout to new medications and the latest in diabetes tech, read our 10 most popular articles from 2021. Continue Reading »

Glucagon is a hormone released by your pancreas that raises the amount of glucose in your blood to help make sure you don’t develop hypoglycemia. Unfortunately, people with type 1 diabetes may have an impaired glucagon response. Researchers are investigating a new medication to stimulate glucagon release, to prevent hypoglycemia for people with type 1 diabetes. Continue Reading »

A clinical trial by Lilly is seeing if your Time in Range could improve from taking Lyumjev, a ultra-rapid mealtime insulin, along with long acting insulin glargine. Continue Reading »

Heart failure is one of the most common diabetes complications. New results from the EMPEROR-Preserved clinical trial show that Jardiance could be the first medication shown to help all people with heart failure. Continue Reading »

HARPdoc, a new educational program, has been evaluated in a clinical trial to determine if it can help people with type 1 diabetes who have an impaired awareness of hypoglycemia. Continue Reading »

If you are currently taking three or more insulin injections per day, you may be eligible to participate in a clinical trial that provides you with the Guardian Connect continuous glucose monitor (CGM) system, InPen smart insulin pen, and smart insulin pen caps. Continue Reading »

Pages